Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02858180 · ClinicalTrials.gov registry record · Phase 4
Hepatitis C Virus(HCV) Heart and Lung Study
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT02858180: Completed Phase 4 study, sponsored by Duke University.
NCT02858180 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02858180, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a multicenter study in Hepatitis C Virus (HCV) infected adult patients who also have advanced cardiac disease or advanced lung disease.
Primary Outcome
The primary safety endpoint is the number of subjects who complete a full course of therapy.
Interventions
- DRUG Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-07-04 |
| Phase | Phase 4 |
What the finished NCT02858180 record still lists
NCT02858180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC) is the first listed.
NCT02858180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02858180 about?
NCT02858180 is a clinical study titled "Hepatitis C Virus(HCV) Heart and Lung Study". This is a multicenter study in Hepatitis C Virus (HCV) infected adult patients who also have advanced cardiac disease or advanced lung disease.
What is the current status of trial NCT02858180?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2016-12. Estimated completion is 2019-07-04.
What interventions are being tested in trial NCT02858180?
The interventions under investigation include: Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC) (DRUG).
Who is sponsoring clinical trial NCT02858180?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02858180's enrollment target sits among peer trials
15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia